JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

JNJ

240

+0.98%↑

UNH

276.41

+2.98%↑

TMO

542.03

+0.18%↑

ABT

110.82

+1.61%↑

ISRG

487.26

+2.36%↑

Начало・Списък с акции・Microbot Medical Inc

Microbot Medical Inc

Затворен

1.77 9.26

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

1.74

Максимум

1.77

Ключови измерители
By Trading Economics
Приходи	-77K -3.6M
Служители	20
EBITDA	-79K -3.6M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+440.12% upside

Дивиденти
By Dow Jones
Следващи печалби	23.03.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-21M 120M
Предишно отваряне	-7.49
Предишно затваряне	1.77

Техническа оценка

By Trading Central

Увереност

Neutral Evidence

2.52 / 2.57 Подкрепа & съпротива

Microbot Medical Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

6.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

6.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

6.02.2026 г., 21:40 ч. UTC

Придобивния, сливания и поглъщания

Verizon Insiders Rarely Sell Company Stock. This Insider Just Did. -- Barrons.com

6.02.2026 г., 21:22 ч. UTC

Пазарно говорене

Mexico's Inflation Seen Accelerating in January -- Market Talk

6.02.2026 г., 21:17 ч. UTC

Печалби

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6.02.2026 г., 21:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

6.02.2026 г., 21:14 ч. UTC

Придобивния, сливания и поглъщания

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- Update

6.02.2026 г., 21:13 ч. UTC

Печалби

How the Software Panic Hit BDC Stocks -- and Why Some Might Be Worth Buying -- Barrons.com

6.02.2026 г., 21:13 ч. UTC

Печалби

Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers -- Barrons.com

6.02.2026 г., 21:04 ч. UTC

Пазарно говорене

Gold Closes Out Volatile Week on Higher Note -- Market Talk

6.02.2026 г., 20:34 ч. UTC

Печалби

Tech Had an Awful Earnings Season. Other Stocks Are Saving the Day. -- Barrons.com

6.02.2026 г., 20:27 ч. UTC

Печалби

These Stocks Are Today's Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More -- Barrons.com

6.02.2026 г., 20:24 ч. UTC

Пазарно говорене

Oil Futures Settle Higher As U.S.-Iran Talks Get Under Way -- Market Talk

6.02.2026 г., 20:20 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Retreat Ahead of Weekend -- Market Talk

6.02.2026 г., 19:48 ч. UTC

Печалби

Take-Two, Mondelez Get Analyst Attention -- Barrons.com

6.02.2026 г., 19:30 ч. UTC

Придобивния, сливания и поглъщания

Justice Department Casts Wide Net on Netflix's Business Practices in Merger Probe -- WSJ

6.02.2026 г., 19:30 ч. UTC

Придобивния, сливания и поглъщания

Justice Department Asking Industry How Netflix or Paramount Deal for Warner Bros. Might Impact Competition, According to Subpoena -- WSJ

6.02.2026 г., 19:30 ч. UTC

Придобивния, сливания и поглъщания

DOJ Asking if Netflix Engaged in 'Exclusionary Conduct' That May Lead to Monopoly, According to Subpoena -- WSJ

6.02.2026 г., 19:17 ч. UTC

Пазарно говорене

USDA Says Farm Income to Decrease in 2026 -- Market Talk

6.02.2026 г., 18:50 ч. UTC

Печалби

Toyota Smashes Earnings Estimates. It's Getting a New CEO. -- Barrons.com

6.02.2026 г., 18:47 ч. UTC

Пазарно говорене

Natural Gas-Infrastructure Operators Take 'Flight to Scale' -- Market Talk

6.02.2026 г., 18:34 ч. UTC

Пазарно говорене

U.S. Oil Rig Count Rises By 1 to 412 -- Market Talk

6.02.2026 г., 17:58 ч. UTC

Печалби

Reddit Stock Falls After Strong Earnings. Wall Street Is Debating What's Next. -- Barrons.com

6.02.2026 г., 17:52 ч. UTC

Пазарно говорене

Печалби

Global Equities Roundup: Market Talk

6.02.2026 г., 17:52 ч. UTC

Пазарно говорене

Печалби

Amazon's CapEx Seen as Misunderstood by Investors -- Market Talk

6.02.2026 г., 17:20 ч. UTC

Пазарно говорене

Tech, Media & Telecom Roundup: Market Talk

6.02.2026 г., 17:20 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

6.02.2026 г., 17:20 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

6.02.2026 г., 17:18 ч. UTC

Пазарно говорене

Canada's Bizarre Jobs Report Points to Growing Labor Slack -- Market Talk

6.02.2026 г., 17:09 ч. UTC

Пазарно говорене

Dollar on Path to Snap Weekly Losing Streak -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Microbot Medical Inc Прогноза

Ценова цел

By TipRanks

440.12% нагоре

12-месечна прогноза

Среден 8.75 USD 440.12%

Висок 12 USD

Нисък 5.5 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Microbot Medical Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Microbot Medical Inc през последните 3 месеца.

Техническа оценка

By Trading Central

2.52 / 2.57Подкрепа & съпротива

The bullish and bearish events are balanced.

Recent bullish events outweigh bearish events.

All events are bullish.

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Microbot Medical Inc

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development; and Phase 2 collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.